menu
    • menu
    [{"orgOrder":0,"company":"Cell and Gene Therapy Catapult","sponsor":"INmune Bio","pharmaFlowCategory":"D","therapeuticArea":"Rare Diseases and Disorders","country":"UNITED KINGDOM","productType":"Cell & Gene Therapy","year":"2025","type":"Partnership","leadProduct":"Umbilical Cord Derived Mesenchymal Stromal Cell","moa":"Undisclosed","graph1":"Rare Diseases and Disorders","graph2":"Phase II","graph3":"Cell and Gene Therapy Catapult","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Rare Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Cell and Gene Therapy Catapult \/ INmune Bio","highestDevelopmentStatusID":"8","companyTruncated":"Cell and Gene Therapy Catapult \/ INmune Bio"}]

    Find Clinical Drug Pipeline Developments & Deals by Cell and Gene Therapy Catapult

    Menu

    Cell and Gene Therapy Catapult

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Cell and Gene Therapy Catapult

                            United Kingdom arrow
                            Global ChemShow
                            Not Confirmed

                            Cell and Gene Therapy Catapult

                            United Kingdom arrow
                            Global ChemShow
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Umbilical Cord Derived Mesenchymal Stromal Cell

                            Therapeutic Area : Rare Diseases and Disorders

                            Study Phase : Phase II

                            Sponsor : INmune Bio

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            INmune Bio Partners with CGT Catapult to Scale up CORDStrom Manufacturing

                            Details : The collaboration will focus on scaling production of CORDStrom, a proprietary pooled, allogeneic, human umbilical cord-derived mesenchymal Stromal/Stem cell (hucMSCs) platform, for RDEB.

                            Product Name : CORDStrom

                            Product Type : Cell & Gene Therapy

                            Upfront Cash : Undisclosed

                            April 14, 2025

                            Lead Product(s) : Umbilical Cord Derived Mesenchymal Stromal Cell

                            Therapeutic Area : Rare Diseases and Disorders

                            Highest Development Status : Phase II

                            Sponsor : INmune Bio

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth